400%+ gains from our recent picks - and Friday's idea
Published: Fri, 12/09/16
![]() SMS alerts can make the difference between a profitable trade and a missed opportunity. Text “alert” to 97000 to receive our instant, reliable and free SMS alerts. Hello fellow investors / traders, While today's trade idea failed to deliver meaningful gains (although it traded in a tight range there some opportunities to buy at low of day and sell at high of day), some of our recent picks have been going insane. We alerted you to TWOH, SSH and RNVA last week and all 3 hit the big time on Thursday. Our alert on SSH was at around $0.20, and after trading mostly sideways for a week, it exploded big on Thursday hitting at high of $0.79 for a 295% gain from our alert price. RNVA similar story - although this one delivered 40% gains the day I alerted it, it pulled back and consolidated, and over the past couple days it went nuts hitting a high of $0.23 for over 100% gains from our alert price last week. TWOH has been a slower grind higher, but we alerted this one at around $0.34 and it delivered 23% gains on the day. It broke out higher again on Thursday hitting $0.465, for a 37% gain from our alert price. Not all of our alerts are winners - there is nobody that can give you a 100% winning rate - if they claim to, they're lying. But our winners far exceed our losers, both in terms of number of picks and % gain. And that is the name of the gain. Sometimes patience is key. For Friday's trading sessions check out EnteroMedics Inc (ETRM). It started to make a move today and could continue on Friday given the hot small cap biotech sector. ETRM has been beaten down in a big way of late, currently trading at just under $0.09 after trading above $0.30 just a few months ago, and well off its 52 week high of $2.85.
There appears to be a decent period of consolidation at these current levels, as well as some recent movement higher, which could mean there is a strong base for a move higher. The small cap biotech market has been hot of late, and many beaten down names have been running big. We think as beaten down as ETRM is, it could be the next to run. If ETRM can break above its 50 day moving average at around $0.095, we could see a test of its 100 day moving average of around $0.2 - that's more than 100% upside. ETRM has a tiny market cap of just over $8m and a decent short interest of 10%. EnteroMedics (ETRM) is a medical device company focused on the development and commercialization of its neuroscience based technology to treat obesity and metabolic diseases. vBloc® Neurometabolic Therapy, delivered by a pacemaker-like device called the vBloc® System, is designed to intermittently block the vagus nerves using high-frequency, low-energy, electrical impulses. EnteroMedics' vBloc® System has received U.S. Food and Drug Administration approval and CE Mark. You can learn more at www.enteromedics.com Recently ETRM provided the market with a commercialization and corporate update, you can check it out at http://finance.yahoo.com/news/enteromedics-provides-commercialization-corporate-120000156.html All the best out there today. To your success,
SmallCapMomo.com-------------------------------------------------------------------------------------------------------- Remember our key trading rules when entering this trade. Capital preservation is key. Keep your stops tight, and if things don't go our way, cut your losses and look for another opportunity. Disclaimer Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. SmallCapMomo.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. The disclaimer is to be read and fully understood before using our site, or joining our email list. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SmallCapMomo.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. SmallCapMomo.com does not offer such advice or analysis, and SmallCapMomo.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, SmallCapMomo.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SmallCapMomo.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents have not completed any due diligence or research on the companies advertised herein and disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SmallCapMomo.com is not responsible for any claims made by the companies advertised herein. SmallCapMomo.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in SmallCapMomo.com statements and opinions and such statements and opinions cannot be considered independent. SmallCapMomo.com reserves the right to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, SmallCapMomo.com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. SmallCapMomo.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. SmallCapMomo.com has not been compensated for the profile of ETRM. SmallCapMomo.com may on occasion accept compensation in restricted or free-trading shares for it's marketing services of the company being profiled, and the third party that might have compensated SmallCapMomo.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If SmallCapMomo.com ever accepts compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services. |